Skip to main content

Zoetis Inc. Q3 FY2026 results

  • ZTS · NYSE
  • Pharmaceuticals
  • S&P 500
$83.82+1.04%Close 13 Nov 2026

Zoetis Inc. reported revenue of $2.39 billion, down 1.3% from a year earlier, net income of $591 million and diluted earnings per share of $1.44 against $1.63 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).

From its quarterly report, filed 5 Nov 2026. Compiled and checked by AapWire.

Q3 FY2026 against Q3 FY2025

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

Zoetis Inc. Q3 FY2026 results against the year-ago quarter
MeasureQ3 FY2026Q3 FY2025Change
Revenue$2.39B$2.42B−1.3%
Gross profit$1.69B$1.73B−1.9%
Gross margin70.8%71.2%−0.4 pts
Operating income$863.0M$932.0M−7.4%
Operating margin36.1%38.5%−2.4 pts
Net income$591.0M$721.0M−18.0%
Diluted EPS$1.44$1.63−11.7%
Operating cash flow$824.0M$936.0M−12.0%
Capital expenditure$107.0M$138.0M−22.5%
Free cash flow$717.0M$798.0M−10.2%

Operating KPIs for the quarter

Zoetis Inc. operating KPIs, Q3 FY2026
KPIQ3 FY2026Change on a year
Dogs and Cats revenue$1.5Bdown 5.6%
Livestock revenue$797.0Mup 6.8%
Parasiticides revenue$576.0Mup 2.7%
Vaccines revenue$540.0Mup 5.5%
Cattle revenue$439.0Mup 5.8%
Dermatology revenue$398.0Mdown 15.7%
Anti-infectives revenue$282.0Mdown 1.7%
Pain and sedation revenue$200.0Munchanged
Animal health diagnostics revenue$128.0Mup 14.3%
Swine revenue$120.0Mup 3.4%
Poultry revenue$108.0Mup 1.9%
Fish revenue$98.0Mup 22.5%
Horses revenue$73.0Mup 5.8%
Sheep and other revenue$32.0Mup 10.3%
Contract manufacturing & human health revenue$29.0Mup 11.5%
Companion Animal revenue$585.0Mup 0.7%
U.S. revenue$1.2Bdown 5.7%
International revenue$1.1Bup 3.9%

Earlier quarters

Zoetis Inc. results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q3 FY202630 Sep 2026$2.39B−1.3%$1.44
Q2 FY202630 Jun 2026$2.47B−0.2%$1.65
Q1 FY202631 Mar 2026$2.26B+2.9%$1.42
Q4 FY202531 Dec 2025$2.37B+2.4%$1.42
Q3 FY202530 Sep 2025$2.42B+1.4%$1.63
Q2 FY202530 Jun 2025$2.47B+4.8%$1.63
Q1 FY202531 Mar 2025$2.20B+0.4%$1.34
Q4 FY202431 Dec 2024$2.32B+4.7%$1.29

More on Zoetis Inc.: financial statements · revenue · earnings per share

ZTS's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.